Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease (Q33872281)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease |
scientific article |
Statements
1 reference
Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease (English)
1 reference
B M Psaty
1 reference
S R Heckbert
1 reference
N S Weiss
1 reference
C D Furberg
1 reference
T D Koepsell
1 reference
D S Siscovick
1 reference
F R Rosendaal
1 reference
N L Smith
1 reference
R C Kaplan
1 reference
D Lin
1 reference
T R Fleming
1 reference
E H Wagner
1 reference
1 August 1999
1 reference
1 reference
282
1 reference
786-790
1 reference
Identifiers
1 reference
1 reference